BioSpace News Archive

BioMidwest

Florida-Based Disaster Management Group Announces 15-Minute COVID-19 Screening Tool

Disaster Management Group, a South Florida-based disaster recovery firm, announced DMGtest, a screening tool for COVID-19 that gives results in 15 minutes.

March 28, 2020
·
2 min read
Policy

Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical products

During this COVID-19 pandemic, the FDA is working around the clock to make sure that Americans have access to safe food and medical products.

March 28, 2020
·
9 min read
Genetown

University of South Florida Health, Northwell Health, Formlabs and Tampa General Hospital Join Forces to Create 3D Printed Nasal Swabs to Test for COVID-19 in Patients in Emergency Shortage Situations

The University of South Florida Health, Formlabs, a leading 3D printing company, and Northwell Health, New York’s largest healthcare provider, announced they have successfully produced and tested a 3D printed nasal swab to address emergency shortages that hospitals and health care teams may face as testing for COVID-19 increases.

March 28, 2020
·
10 min read
Drug Development

Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol

Study Met Primary Endpoint (Change From Baseline in LDL-C) and All Secondary Endpoints Repatha is the First PCSK9 Inhibitor to Demonstrate LDL-C Lowering Results in People Living with HIV [28-March-2020] THOUSAND OAKS, Calif. , March 28, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced positive results from the Evolocuma B E ffect on LDL-C Lower I

March 28, 2020
·
16 min read
Drug Development

Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

- Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials showed inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 months(1) - Prespecified exploratory analysis based on safety reporting from the three trials, showed fewer major adverse cardiovascular events (MACE) with inclisiran compared to placebo(1) - The data are consistent with LDL-C lowering as a strong surrogate for improved patient cardiovascular outcomes(2)

March 28, 2020
·
12 min read
BioMidwest

Disaster Management Group Launches New App to Streamline COVID-19 Testing

Disaster Management Group, a Florida-based disaster recovery firm, has partnered with software developer Promero to launch an app that will provide scheduling services for COVID-19 testing sites nationwide.

March 28, 2020
·
4 min read
Policy

ALERT, ROSEN, GLOBAL INVESTOR COUNSEL, Reminds LogicBio Therapeutics, Inc. Investors of Important Deadline in Securities Class Action Commenced by the Firm

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. between December 3, 2018 and February 10, 2020, inclusive of the important May 18, 2020 lead plaintiff deadline in the case.

March 28, 2020
·
2 min read
Cottonelle® and Kleenex® Brands ask Canadians to #ShareASquareCanada and Commit $100,000 to United Way Centraide Canada’s COVID-19 Community Response and Recovery Fund

The brands will also donate $1 for every use of hashtag #ShareASquareCanada and provide product to those in need

March 28, 2020
·
4 min read
Drug Development

FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial

New data showed consistent effect of FARXIGA in patients with heart failure with reduced ejection fraction, regardless of background therapy

March 28, 2020
·
7 min read